|
IPO5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.69690000000933E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.049900E-04 |
| Normal-vs-Stage2 |
6.424300E-04 |
| Normal-vs-Stage3 |
2.01089999999349E-05 |
| Normal-vs-Stage4 |
8.24830000000221E-05 |
| Stage1-vs-Stage2 |
5.407200E-01 |
| Stage1-vs-Stage3 |
2.311000E-01 |
| Stage1-vs-Stage4 |
2.620000E-01 |
| Stage2-vs-Stage3 |
8.460600E-01 |
| Stage2-vs-Stage4 |
7.864400E-01 |
| Stage3-vs-Stage4 |
9.100200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.70669999999862E-05 |
| Normal-vs-AfricanAmerican |
5.936800E-01 |
| Normal-vs-Asian |
2.356300E-04 |
| Caucasian-vs-AfricanAmerican |
2.698800E-01 |
| Caucasian-vs-Asian |
7.186400E-01 |
| AfricanAmerican-vs-Asian |
2.264000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.35809999982584E-07 |
| Normal-vs-Female |
5.964600E-04 |
| Male-vs-Female |
5.569600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.121100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.3554999995532E-07 |
| Normal-vs-Age(61-80Yrs) |
6.40880000000177E-05 |
| Normal-vs-Age(81-100Yrs) |
5.579700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.816100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.470420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.712400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.951600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.683600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.217200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.453400E-01 |
| Classical-VS-Follicular |
2.509000E-01 |
| Classical-VS-Other |
1.674840E-01 |
| Classical-VS-Normal |
3.595900E-04 |
| Tall-VS-Follicular |
7.431600E-01 |
| Tall-VS-Other |
3.026600E-01 |
| Tall-VS-Normal |
6.078400E-03 |
| Follicular-VS-Other |
2.227600E-01 |
| Follicular-VS-Normal |
2.583100E-04 |
| Other-VS-Normal |
3.896600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07909999999645E-05 |
| Normal-vs-N1 |
8.36339999999991E-05 |
| N0-vs-N1 |
4.317400E-01 |
|
|
